Overview A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Pediatric Atopic Dermatitis Status: Completed Trial end date: 2018-10-01 Target enrollment: Participant gender: Summary This is a phase 1 and 2 study to assess the safety and efficacy of PAC-14028 cream in children with atopic dermatitis. Phase: Phase 1/Phase 2 Details Lead Sponsor: Amorepacific Corporation